Skip to content

Intra Versus Extrahepatic Division of Right Hepatic Vein During Rightsided Hemihepatectomy

Randomized Phase 2 Study of Intra Versus Extrahepatic Division of Right Hepatic Vein During Rightsided Hemihepatectomy

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02041078
Enrollment
100
Registered
2014-01-20
Start date
2011-05-31
Completion date
2017-07-31
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reduction of Peroperative Blood Loss During Liver Resection

Keywords

Liver surgery, Blood loss, CUSA, Hepatic transection

Brief summary

Intrahepatic division of the hepatic vein is associated with less blood loss than extrahepatic dissection and division of the right hepatic vein.

Interventions

PROCEDUREIntrahepatic division of the right hepatic vein.

Ligation and division of the entrance of the right hepatic vein into the suprarenal cava vein are done at the end of transection of the liver parenchyma with CUSA.

PROCEDUREExtrahepatic vein division

Standard surgical procedure with extrahepatic ligation/division of the right hepatic vein prior to parenchymal division with CUSA.

Sponsors

Jansson, Anders, M.D.
CollaboratorINDIV
Bengt Isaksson
CollaboratorUNKNOWN
Karolinska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Hepatic lesion amenable to right sided hemihepatectomy.

Exclusion criteria

* Hepatic lesions not suitable for a anatomical right sided hemihepatectomy. * Unfit for surgery * Unwillingness to participate

Design outcomes

Primary

MeasureTime frame
Intraoperative bloodlossIntraoperative time (in minutes) for the division of the liver parenchyma

Secondary

MeasureTime frame
Operation time, postoperative complication rateTotal time in minutes spent in theater, in hospital stay in days (on an average less than 30 days), total complication rate during hospital stay (on an average less than 30 days), surgical complications during in hospital stay (on an average<30days).
postoperative complication ratein hospital stay in days (on an average <30 days), total complication rate during hospital stay (on an average <30 days), surgical complications during in hospital stay (on an average <30 days).

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026